Safety and Tolerability of Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) - a Pilot Study
Clinical trial NCT07660107 · COMPLETED
Trial details
- NCT number
- NCT07660107
- Sponsor
- Kioga Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-07
- Primary completion
- 2025-07-15
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.